11th Nov 2016 07:19
LONDON (Alliance News) - Pharmaceuticals and healthcare services company Clinigen Group PLC on Friday said trading in its current financial year has been in line with its expectations.
In a statement to be given at the company's annual general meeting, taking place on Friday, Clinigen Chairman Peter Allen said the group has delivered a strong financial performance in its current financial year, to the end of June 2017.
He said adjusted earnings in its financial year to date have increased 25%, driven by good organic growth and the contribution from acquisitions the firm has made.
"Our focus is now fixed on leveraging our global leadership positions, and we will continue to drive organic growth supported by acquisitions and the revitalisation of products," Allen said.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
CLIN.L